AIM-listed Roebuck Food Group has raised €9.0 million in a placing and subscription to fund Galway biotech GlasPort Bio, maker of the GasAbate slurry additive, and its sister firm GlasPort Rumen Tech. Shareholders vote on 30 November.
By Sreepriya Prasannan
Merck KGaA will not take zerlasiran, the Lp(a)-lowering drug it is set to gain by buying Silence Therapeutics, into late-stage trials. Its healthcare chief told investors on 12 November 2026 that the Lp(a) project would not be pursued, after Novartis's pelacarsen failed to cut heart attacks and strokes.
By Sreepriya Prasannan
The FDA approved Bayer's Sunharbo (asundexian) on 9 November 2026, the first Factor XIa inhibitor, to lower the risk of another stroke after a non-cardioembolic ischaemic stroke or high-risk TIA. It is still under EMA review, so it is not yet available in Ireland.
By Sreepriya Prasannan
Funds managed by Blackstone will pay up to $1.5 billion of development costs for berobenatide, Pfizer's investigational monthly GLP-1 obesity injection, through 2028. Blackstone gets milestone payments, not rights, and Pfizer keeps full control of the programme.
By Sreepriya Prasannan
A Microsoft 365 outage that began on Thursday evening, Irish time, left many users without Outlook email and parts of Teams, SharePoint and Copilot into Friday 13 November. Microsoft reported only partial recovery overnight and said it had no indication of malicious activity.
By Sreepriya Prasannan
Pharmaceutical · 13 Nov
Merck KGaA Drops Silence's Lp(a) Drug After Novartis Miss
Regulatory Affairs · 13 Nov
FDA Approves Bayer's Sunharbo, First Factor XIa Stroke Pill
Pharmaceutical · 13 Nov
Pfizer Gets Up to $1.5bn From Blackstone for Obesity Drug
Industry · 13 Nov
Microsoft 365 Outage: Outlook and Teams Down Into Friday
Each night we collect clinical trial, medicine shortage and marketing authorisation records directly from ClinicalTrials.gov, the EU Clinical Trials Information System, BfArM and the HPRA. Each figure below is the overnight count and shows the time its register was read. Each one links to the full dataset and its source.
Overnight counts from ClinicalTrials.gov, CTIS, BfArM and the HPRA. Tap a figure for its source.
284 articles · 84,715 article views · 7 topics · 14 free tools
Pharmaceutical · 16 Oct 2026
Leah Fletcher, founder and CEO of Athlone's Dunbar Pharma, Ireland's first EU GMP-certified cannabinoid pharmaceutical manufacturer, is Enterprise Ireland's HPSU Founder of the Year 2026. Her path from teacher to pharma founder, the company and its plant-derived dronabinol.
Sreepriya Prasannan · 11 min read
12 Nov 2026 · 15 min
Ireland's pharma and medtech sector employed a record 96,848 people in 2025, CSO data shows. Our year-end report covers 2026 hiring and cuts, work permits, salaries, how Ireland compares with Europe, and what official forecasts say about 2027.
9 Nov 2026 · 8 min
Ireland ranks second behind the US in the Global Industry Competitiveness Index 2026 from BAK Economics and scienceindustries, but the report says productivity is driven by multinational profits and flags weak growth and below average innovation.
7 Nov 2026 · 6 min
Airmid Éireann 1.6 adds 61,683 clinical trials with sites in India and China, the Swiss list of reimbursed medicines with prices, and Czech medicine and supply data, bringing Ireland's open pharma data project to 76 datasets.
All Industry stories121 articles
10 Nov 2026 · 11 min
A new paper finds only one of 3,011 FDA warning letters treated a firm's own use of AI as a violation. We read the April 2026 letter to Purolea Cosmetics Lab and set out what it means for Irish GMP teams as EU Annex 22 stays in draft.
5 Nov 2026 · 7 min
Chinese and Indian developers won 17 US and EU biosimilar approvals in 2026 while Korean firms won none this year. Samsung Bioepis and Celltrion are now racing to copy MSD's Keytruda, a cancer drug partly made in Swords, Co Dublin.
5 Nov 2026 · 7 min
Indian regulators ordered Sun Pharma to stop making and selling eye-care products from its Assam plant after an inspection found quality system failures, Reuters reported. Sun Pharma says it paused production voluntarily. None of the brands is authorised in Ireland.
All Regulatory Affairs stories64 articles
7 Nov 2026 · 10 min
The US FDA has granted accelerated approval to Johnson & Johnson's Rybrevant Faspro for previously treated recurrent or metastatic head and neck squamous cell carcinoma, based on a 42% response rate in 102 patients. It has no EU authorisation for this use, and survival benefit is still to be confirmed.
22 Oct 2026 · 6 min
Clonmel Healthcare, the Irish affiliate of STADA, has launched Mabelle Menocare, four hormone-free food supplements for perimenopause and menopause containing Trifolibrin, which the company describes as red clover and hops extracts.
13 Oct 2026 · 6 min
Carlyle-backed women's health company Millicent Pharma is making a multimillion pound investment in automation and capacity at its Larne plant, creating more than 20 jobs and taking the site's workforce from 50 to 70.
All Pharmaceutical stories36 articles
11 Nov 2026 · 7 min
Irish Medtech has named the finalists for the Irish Medtech Awards 2026 after what it calls a record number of entries. Twenty-two organisations are shortlisted across nine categories, with winners due at Medtech Rising in Galway in December.
8 Nov 2026 · 8 min
Belfast company PulseAI says the US FDA has granted 510(k) clearance for its AI arrhythmia model for wearables. We check the claim that inconclusive smartwatch ECGs fall from 20% to near-zero against the release, the FDA data and the published studies.
30 Oct 2026 · 10 min
Dublin start-up Coroflo is selling Coro, a nipple-shield breastfeeding monitor that measures milk intake, in Ireland and in the UK through John Lewis. It is a consumer product, not a medical device, and independent studies are under way.
All MedTech stories24 articlesEvery dataset states what it holds and when it was last read.
Counts as of the last nightly read, not estimates.
The longest recent analysis, five minutes or more.
Long read · 9 min
Cancer Trials Ireland says 2.9% of people with cancer joined interventional trials in 2025, less than half the 6% National Cancer Strategy target. Its new report estimates €6.51 million in avoided drug costs, but the latest State KPI report we could find gives no measured figure.
Sreepriya Prasannan · 7 Nov 2026
Long read · 8 min
Cork biotech ArrayPatch has closed an oversubscribed €3.2 million seed round. WakeUp Capital joins the investors and the board, and a pre-clinical GLP-1 patch for obesity and diabetes is now the company's main focus.
Sreepriya Prasannan · 5 Nov 2026
Long read · 7 min
Breakthrough Cancer Research has published a free second edition of Menopause, Diet & Cancer, a 164-page nutrition guide and recipe book from UCC dietitians for women whose menopause was caused by cancer treatment. It grew out of the LYSA trial.
Sreepriya Prasannan · 4 Nov 2026An ATS-ready life science CV: 13 templates, a live readiness score, AI tailoring against any job advert, PDF or Word export.
Open the studio Free · browser onlyBold, italic and Unicode styles for posts, keyword-rich headline guidance, and profile guides written for pharma recruiters in Ireland.
Open the formatter Official statisticsRole-level pay for Ireland, the EU, the UK and the US from official statistics, by role and region. Benchmark before the conversation.
Open the guidesNo account, no upload, nothing leaves your browser.
13 ATS-ready templates, a live readiness score with fix-it guidance, AI tailoring against any job advert, and real PDF, Word and plain-text export.
Sample keyword coverage · pharma QAA post formatter with bold, italic and Unicode styles, keyword-rich headline guidance, and step-by-step profile guides written for pharma recruiters in Ireland.
Format your postsRoles at MSD, Pfizer, J&J, Regeneron and 280+ Irish pharma employers, with the salary guides and CV tools to go with them.
Sreepriya Prasannan is the founder and editor of Priya Life Science, covering Ireland's pharmaceutical and life science industries. Holding an MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany, she bridges the gap between complex regulatory compliance and cutting-edge software solutions.
Her work in digital health was nationally recognised when she was selected as a Top 14 finalist in the HSE Spark Ignite 2026 Innovation Programme. Driven by a passion for open-source science and industry transparency, she founded Priya Life Science as a collaborative knowledge platform for researchers, QA leads, clinical operations directors and students across Ireland and Europe.
Deep experience in quality assurance, regulatory compliance, data integrity and aseptic processing, alongside academic grounding in botany and life sciences: the lab bench and the audit trail.
